Avandia injuries, consisting of cardiac events such as heart attack, have affected thousands of individuals taking Avandia for Type II diabetes. Type II diabetics should be aware that Avandia carries these risks. Avandia injuries have been investigated by the FDA, which issued a black box warning for the drug in 2007. The “black box warning” is the strongest the FDA can issue and is used to warn users that a drug carries significant risk of serious or life threatening side effects. The increased cardiovascular risk of Avandia injuries means that use of the drug can be serious or even fatal. This is especially important for those with Type II diabetes, as that condition itself carries an increased risk of heart attack.
Avandia injuries have been directly correlated with heart attacks and other “cardiac events” in numerous studies. Read More→
